Danaher Corporation $DHR Stock Holdings Reduced by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company cut its position in shares of Danaher Corporation (NYSE:DHR) by 5.3% in the first quarter, Holdings Channel reports. The firm owned 2,232,756 shares of the conglomerate’s stock after selling 126,100 shares during the period. The Manufacturers Life Insurance Company’s holdings in Danaher were worth $423,328,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd raised its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the period. JPL Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth about $25,000. Finally, Main Street Group LTD bought a new position in Danaher in the 1st quarter worth approximately $25,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on DHR. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Argus decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. TD Cowen cut their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Finally, Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Up 2.6%

DHR opened at $196.57 on Tuesday. The firm has a market cap of $138.19 billion, a price-to-earnings ratio of 34.92, a PEG ratio of 2.38 and a beta of 0.79. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm’s 50-day simple moving average is $186.29 and its 200-day simple moving average is $196.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm posted $0.77 EPS. Equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is 28.42%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.